Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Selective cytotoxicity and combined effects of camptothecin or paclitaxel with sodium-R-alpha lipoate on A549 human non-small cell lung cancer cells.

Ibrahim S, Gao D, Sinko PJ.

Nutr Cancer. 2014;66(3):492-9. doi: 10.1080/01635581.2013.749290. Epub 2013 Sep 24.

2.
3.

In vitro schedule-dependent interaction between irinotecan and vinorelbine in NCI H460 non-small cell lung cancer cell line.

Gauvin A, Bressolle F, Martineau P, Astre C, Pinguet F.

Anticancer Res. 2002 Mar-Apr;22(2A):905-12.

PMID:
12014670
4.

Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines.

Kaufmann SH, Peereboom D, Buckwalter CA, Svingen PA, Grochow LB, Donehower RC, Rowinsky EK.

J Natl Cancer Inst. 1996 Jun 5;88(11):734-41.

PMID:
8637027
6.

Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines.

Edelman MJ, Quam H, Mullins B.

Cancer Chemother Pharmacol. 2001 Aug;48(2):141-4.

PMID:
11561780
7.

Effect of CPT-11 in combination with other anticancer agents in lung cancer cells.

Pei XH, Nakanishi Y, Takayama K, Bai F, Kawasaki M, Tsuruta N, Mizuno K, Hara N.

Anticancer Drugs. 1997 Mar;8(3):231-7.

PMID:
9095327
8.

Angiocytotoxic therapy in human non-small cell lung cancer cell lines--advantage of combined effects of TNP-470 and SN-38.

Satoh H, Ishikawa H, Fujimoto M, Fujiwara M, Yamashita YT, Yazawa T, Ohtsuka M, Hasegawa S, Kamma H.

Acta Oncol. 1998;37(1):85-90.

PMID:
9572659
9.

Combined effects of TNP-470 and taxol in human non-small cell lung cancer cell lines.

Satoh H, Ishikawa H, Fujimoto M, Fujiwara M, Yamashita YT, Yazawa T, Ohtsuka M, Hasegawa S, Kamma H.

Anticancer Res. 1998 Mar-Apr;18(2A):1027-30.

PMID:
9615759
10.

Synergistic antitumor effect of α-pinene and β-pinene with paclitaxel against non-small-cell lung carcinoma (NSCLC).

Zhang Z, Guo S, Liu X, Gao X.

Drug Res (Stuttg). 2015 Apr;65(4):214-8. doi: 10.1055/s-0034-1377025. Epub 2014 Sep 4.

PMID:
25188609
11.

Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice.

Shen H, Hu D, Du J, Wang X, Liu Y, Wang Y, Wei JM, Ma D, Wang P, Li L.

Eur J Pharmacol. 2008 Dec 28;601(1-3):23-9. doi: 10.1016/j.ejphar.2008.10.035. Epub 2008 Oct 28.

PMID:
18983839
12.

Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.

Honore S, Kamath K, Braguer D, Horwitz SB, Wilson L, Briand C, Jordan MA.

Cancer Res. 2004 Jul 15;64(14):4957-64.

13.

Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer.

Socinski MA, Sandler AB, Miller LL, Locker PK, Hanover CK, Elfring GL, Israel VK, Pirotta N, Natale RB.

J Clin Oncol. 2001 Feb 15;19(4):1078-87.

PMID:
11181672
14.

A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancer.

Hotta K, Ueoka H, Kiura K, Tabata M, Kuyama S, Satoh K, Kozuki T, Hisamoto A, Hosokawa S, Fujiwara K, Tanimoto M.

Lung Cancer. 2004 Jul;45(1):77-84.

PMID:
15196737
15.

HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin.

Chen SZ, Jiang M, Zhen YS.

Cancer Chemother Pharmacol. 2005 Aug;56(2):212-20. Epub 2005 Apr 6.

PMID:
15812674
16.

Vorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells.

Owonikoko TK, Ramalingam SS, Kanterewicz B, Balius TE, Belani CP, Hershberger PA.

Int J Cancer. 2010 Feb 1;126(3):743-55. doi: 10.1002/ijc.24759.

17.
18.

Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis.

Nguyen DM, Lorang D, Chen GA, Stewart JH 4th, Tabibi E, Schrump DS.

Ann Thorac Surg. 2001 Aug;72(2):371-8; discussion 378-9.

PMID:
11515869
19.

[Developed new agents for lung cancer].

Kato Y, Saijo N.

Nihon Geka Gakkai Zasshi. 2002 Feb;103(2):218-23. Review. Japanese.

PMID:
11904983
20.

Supplemental Content

Support Center